Tekla Healthcare Investors Competitors

Tekla Healthcare Investors (NYSE:HQH) and DNP Select Income Fund (NYSE:DNP) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

Dividends

Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. DNP Select Income Fund pays an annual dividend of $0.78 per share and has a dividend yield of 7.7%. Tekla Healthcare Investors has raised its dividend for 1 consecutive years and DNP Select Income Fund has raised its dividend for 1 consecutive years.

Volatility & Risk

Tekla Healthcare Investors has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, DNP Select Income Fund has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Profitability

This table compares Tekla Healthcare Investors and DNP Select Income Fund's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Tekla Healthcare Investors and DNP Select Income Fund's gross revenue, earnings per share and valuation.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Tekla Healthcare Investors and DNP Select Income Fund, as reported by MarketBeat.com.

Insider & Institutional Ownership

22.2% of Tekla Healthcare Investors shares are held by institutional investors. Comparatively, 5.7% of DNP Select Income Fund shares are held by institutional investors. 7.3% of Tekla Healthcare Investors shares are held by insiders. Comparatively, 0.1% of DNP Select Income Fund shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Tekla Healthcare Investors beats DNP Select Income Fund on 4 of the 4 factors compared between the two stocks.

Tekla Healthcare Investors (NYSE:HQH) and Nuveen Municipal Value Fund (NYSE:NUV) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

Insider & Institutional Ownership

22.2% of Tekla Healthcare Investors shares are held by institutional investors. Comparatively, 12.7% of Nuveen Municipal Value Fund shares are held by institutional investors. 7.3% of Tekla Healthcare Investors shares are held by insiders. Comparatively, 1.0% of Nuveen Municipal Value Fund shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Tekla Healthcare Investors has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Nuveen Municipal Value Fund has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Tekla Healthcare Investors and Nuveen Municipal Value Fund, as reported by MarketBeat.com.

Dividends

Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Nuveen Municipal Value Fund pays an annual dividend of $0.37 per share and has a dividend yield of 3.3%. Tekla Healthcare Investors has raised its dividend for 1 consecutive years and Nuveen Municipal Value Fund has raised its dividend for 1 consecutive years.

Earnings and Valuation

This table compares Tekla Healthcare Investors and Nuveen Municipal Value Fund's gross revenue, earnings per share and valuation.

Profitability

This table compares Tekla Healthcare Investors and Nuveen Municipal Value Fund's net margins, return on equity and return on assets.

Summary

Tekla Healthcare Investors beats Nuveen Municipal Value Fund on 4 of the 4 factors compared between the two stocks.

Adams Diversified Equity Fund (NYSE:ADX) and Tekla Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

Insider & Institutional Ownership

14.9% of Adams Diversified Equity Fund shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 0.2% of Adams Diversified Equity Fund shares are held by insiders. Comparatively, 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Adams Diversified Equity Fund has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for Adams Diversified Equity Fund and Tekla Healthcare Investors, as reported by MarketBeat.

Dividends

Adams Diversified Equity Fund pays an annual dividend of $1.03 per share and has a dividend yield of 5.4%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Adams Diversified Equity Fund has increased its dividend for 1 consecutive years and Tekla Healthcare Investors has increased its dividend for 1 consecutive years.

Valuation and Earnings

This table compares Adams Diversified Equity Fund and Tekla Healthcare Investors' revenue, earnings per share and valuation.

Profitability

This table compares Adams Diversified Equity Fund and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Summary

Tekla Healthcare Investors beats Adams Diversified Equity Fund on 4 of the 4 factors compared between the two stocks.

PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) and Tekla Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

Insider & Institutional Ownership

6.9% of PIMCO Corporate & Income Opportunity Fund shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

PIMCO Corporate & Income Opportunity Fund has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for PIMCO Corporate & Income Opportunity Fund and Tekla Healthcare Investors, as reported by MarketBeat.

Dividends

PIMCO Corporate & Income Opportunity Fund pays an annual dividend of $1.56 per share and has a dividend yield of 8.3%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. PIMCO Corporate & Income Opportunity Fund has increased its dividend for 1 consecutive years and Tekla Healthcare Investors has increased its dividend for 1 consecutive years.

Valuation and Earnings

This table compares PIMCO Corporate & Income Opportunity Fund and Tekla Healthcare Investors' revenue, earnings per share and valuation.

Profitability

This table compares PIMCO Corporate & Income Opportunity Fund and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Summary

Tekla Healthcare Investors beats PIMCO Corporate & Income Opportunity Fund on 3 of the 4 factors compared between the two stocks.

Goldman Sachs BDC (NYSE:GSBD) and Tekla Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

Valuation and Earnings

This table compares Goldman Sachs BDC and Tekla Healthcare Investors' revenue, earnings per share and valuation.

Goldman Sachs BDC has higher revenue and earnings than Tekla Healthcare Investors.

Profitability

This table compares Goldman Sachs BDC and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings for Goldman Sachs BDC and Tekla Healthcare Investors, as reported by MarketBeat.

Goldman Sachs BDC presently has a consensus target price of $15.9167, suggesting a potential downside of 17.91%. Given Goldman Sachs BDC's higher probable upside, analysts clearly believe Goldman Sachs BDC is more favorable than Tekla Healthcare Investors.

Insider & Institutional Ownership

13.8% of Goldman Sachs BDC shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 0.3% of Goldman Sachs BDC shares are held by insiders. Comparatively, 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Dividends

Goldman Sachs BDC pays an annual dividend of $1.80 per share and has a dividend yield of 9.3%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Goldman Sachs BDC pays out 90.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Goldman Sachs BDC has increased its dividend for 1 consecutive years and Tekla Healthcare Investors has increased its dividend for 1 consecutive years.

Risk & Volatility

Goldman Sachs BDC has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Summary

Goldman Sachs BDC beats Tekla Healthcare Investors on 8 of the 11 factors compared between the two stocks.

Hercules Capital (NYSE:HTGC) and Tekla Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings and Valuation

This table compares Hercules Capital and Tekla Healthcare Investors' revenue, earnings per share (EPS) and valuation.

Hercules Capital has higher revenue and earnings than Tekla Healthcare Investors.

Profitability

This table compares Hercules Capital and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Hercules Capital and Tekla Healthcare Investors, as provided by MarketBeat.com.

Hercules Capital currently has a consensus price target of $13.8438, suggesting a potential downside of 18.08%. Given Hercules Capital's higher probable upside, equities analysts clearly believe Hercules Capital is more favorable than Tekla Healthcare Investors.

Insider and Institutional Ownership

28.9% of Hercules Capital shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 3.3% of Hercules Capital shares are held by insiders. Comparatively, 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Dividends

Hercules Capital pays an annual dividend of $1.28 per share and has a dividend yield of 7.6%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Hercules Capital pays out 90.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Hercules Capital has raised its dividend for 1 consecutive years and Tekla Healthcare Investors has raised its dividend for 1 consecutive years.

Volatility and Risk

Hercules Capital has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.

Summary

Hercules Capital beats Tekla Healthcare Investors on 8 of the 11 factors compared between the two stocks.